EATG » Tags

Tags

Health Canada approves DAKLINZA (daclatasvir) for difficult-to-treat hepatitis C patient populations

DAKLINZA is approved in Canada in combination with other agents for the treatment of chronic hepatitis C patients with HIV co-infection, advanced cirrhosis and post-liver transplant HCV recurrence MONTREAL, May…

First Canadian study demonstrates potential to remove patients from active liver transplant list after curing hepatitis C

"The days of hepatitis C dominating liver transplantation are numbered" LONDON, ON, May 3, 2016 - Researchers with the Multi-Organ Transplant Program at London Health Sciences Centre and the Lawson Health Research Institute…